Phibro Animal Health Dirección
Dirección controles de criterios 4/4
El CEO de Phibro Animal Health's es Jack Bendheim , nombrado en Jan 1988, tiene una permanencia de 36.25 años. compensación anual total es $2.94M, compuesta por 77.2% salario y 22.8% primas, incluidas acciones y opciones de la empresa. posee directamente un 49.94% de las acciones de la empresa, por valor de $263.94M. La antigüedad media del equipo directivo y de la junta directiva es de 6.5 años y 14.8 años, respectivamente.
Información clave
Jack Bendheim
Chief Executive Officer (CEO)
US$2.9m
Compensación total
| Porcentaje del salario del CEO | 77.2% |
| Permanencia del CEO | 36.3yrs |
| Participación del CEO | 49.9% |
| Permanencia media de la dirección | 6.5yrs |
| Promedio de permanencia en la Junta Directiva | 14.8yrs |
Actualizaciones recientes de la dirección
Recent updates
Market Participants Recognise Phibro Animal Health Corporation's (NASDAQ:PAHC) Earnings Pushing Shares 30% Higher
Apr 30
Phibro Animal Health (NASDAQ:PAHC) Is Due To Pay A Dividend Of $0.12
Feb 10Phibro Animal Health (NASDAQ:PAHC) Use Of Debt Could Be Considered Risky
Dec 06Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be $0.12
Nov 10A Look At The Fair Value Of Phibro Animal Health Corporation (NASDAQ:PAHC)
Nov 05Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12
Aug 28Phibro Animal Health (NASDAQ:PAHC) Is Paying Out A Dividend Of $0.12
Jul 29Phibro Animal Health (NASDAQ:PAHC) Is Due To Pay A Dividend Of $0.12
Feb 10Is Phibro Animal Health Corporation (NASDAQ:PAHC) Worth US$13.8 Based On Its Intrinsic Value?
Dec 23Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be $0.12
Aug 26Phibro Animal Non-GAAP EPS of $0.36 misses by $0.02, revenue of $255.3M beats by $5.26M
Aug 24Is Phibro Animal Health (NASDAQ:PAHC) A Risky Investment?
Aug 24Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12
Jul 29Phibro Animal declares $0.12 dividend
Jul 25Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be US$0.12
May 06Phibro Animal Health (NASDAQ:PAHC) Has Announced A Dividend Of US$0.12
Feb 11Phibro Animal Health (NASDAQ:PAHC) Has Re-Affirmed Its Dividend Of US$0.12
Nov 05We Discuss Why Phibro Animal Health Corporation's (NASDAQ:PAHC) CEO Compensation May Be Closely Reviewed
Oct 26Does Phibro Animal Health (NASDAQ:PAHC) Have A Healthy Balance Sheet?
Aug 26Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | US$15m |
| Sep 30 2023 | n/a | n/a | US$21m |
| Jun 30 2023 | US$3m | US$2m | US$33m |
| Mar 31 2023 | n/a | n/a | US$29m |
| Dec 31 2022 | n/a | n/a | US$36m |
| Sep 30 2022 | n/a | n/a | US$46m |
| Jun 30 2022 | US$4m | US$2m | US$49m |
| Mar 31 2022 | n/a | n/a | US$59m |
| Dec 31 2021 | n/a | n/a | US$53m |
| Sep 30 2021 | n/a | n/a | US$49m |
| Jun 30 2021 | US$4m | US$2m | US$54m |
| Mar 31 2021 | n/a | n/a | US$43m |
| Dec 31 2020 | n/a | n/a | US$44m |
| Sep 30 2020 | n/a | n/a | US$43m |
| Jun 30 2020 | US$3m | US$2m | US$34m |
| Mar 31 2020 | n/a | n/a | US$37m |
| Dec 31 2019 | n/a | n/a | US$38m |
| Sep 30 2019 | n/a | n/a | US$41m |
| Jun 30 2019 | US$3m | US$2m | US$55m |
| Mar 31 2019 | n/a | n/a | US$68m |
| Dec 31 2018 | n/a | n/a | US$73m |
| Sep 30 2018 | n/a | n/a | US$65m |
| Jun 30 2018 | US$3m | US$2m | US$65m |
| Mar 31 2018 | n/a | n/a | US$58m |
| Dec 31 2017 | n/a | n/a | US$62m |
| Sep 30 2017 | n/a | n/a | US$68m |
| Jun 30 2017 | US$3m | US$2m | US$65m |
Compensación vs. Mercado: La compensación total ($USD2.94M) de Jack está en línea con el promedio de empresas de tamaño similar en el mercado US ($USD2.37M).
Compensación vs. Ingresos: La compensación de Jack ha sido consistente con los resultados de la empresa en el último año.
CEO
Jack Bendheim (76 yo)
36.3yrs
Permanencia
US$2,938,899
Compensación
Mr. Jack Clifford Bendheim has been the President and Chief Executive Officer of Phibro Animal Health Corporation since 1988 and March 2014, respectively and serves as its Chairman. Mr. Bendheim served as...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman | 36.3yrs | US$2.94m | 49.94% $ 337.8m | |
| Chief Operating Officer | 7.8yrs | US$778.80k | 0.074% $ 501.0k | |
| Executive VP of Corporate Strategy & Director | 10.1yrs | US$554.69k | sin datos | |
| President of North America Region | 4.9yrs | US$619.27k | sin datos | |
| Chief Financial Officer | less than a year | sin datos | sin datos | |
| Senior VP | less than a year | sin datos | sin datos | |
| Senior Vice President of Human Resources | 7.1yrs | sin datos | sin datos | |
| President of MACIE Region | no data | sin datos | sin datos | |
| President South America Region | 6.8yrs | sin datos | sin datos | |
| President of Asia Pacific Region | less than a year | sin datos | sin datos | |
| President of PhibroChem and Ethanol Performance Group | no data | sin datos | sin datos | |
| VP of Finance & Treasurer | 6.1yrs | sin datos | sin datos |
6.5yrs
Permanencia media
54yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de PAHC es experimentado (6.5 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman | 40.3yrs | US$2.94m | 49.94% $ 337.8m | |
| Executive VP of Corporate Strategy & Director | 10.4yrs | US$554.69k | sin datos | |
| President of MACIE Region | 5.7yrs | sin datos | sin datos | |
| Independent Non-Executive Director | 20.3yrs | US$60.00k | sin datos | |
| Independent Non Executive Director | 19.9yrs | US$40.00k | sin datos | |
| Independent Director | 13.8yrs | US$60.00k | 0.0025% $ 16.7k | |
| Independent Non-Executive Director | 15.9yrs | US$50.00k | 0.049% $ 334.0k | |
| Independent Director | 1.2yrs | US$22.50k | sin datos |
14.8yrs
Permanencia media
64yo
Promedio de edad
Junta con experiencia: Los miembros de la junta directiva de PAHC son experimentados ( 14.8 años antigüedad media).